Author Fred Litwin's New Book Claims to Debunk Oliver
Extensively Sourced Book Shows How Clever Filmmaking Can Mislead the Public...
Globe Newswire31-01-2023, 01:38
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26